Moreover, GP130 pathway inhibition may convey potent anti-tumor effects [24], so we examined PreAdip cells as a possible source of IL6 and its impacts on DDLPS oncogenic behaviors via GP130 signaling. The gene discussed is IL6ST; the disease is neoplasm.